Clinical Trials Browser

NIH × Interventional × Hypercalcemia × Clear all

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

NCT01447914 2019-08-28

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Classical hematologyOther hematologic neoplasmPlasma cell

Amyloidosis, Anemia, Bone Diseases, Metabolic, Fractures, Spontaneous, Hypercalcemia, Multiple Myeloma, Osteolysis, Paraproteinemias, Hematologic Neoplasms, Renal Insufficiency

NCT00325104 2017-07-02

Cinacalcet to Treat Familial Primary Hyperparathyroidism

Phase 3 Completed

25 enrolled

EndocrineHead & Neck

Hyperparathyroidism 1, Hypercalcemia, Insulinoma, Multiple Endocrine Neoplasia, Gastrinoma, Carcinoma, Medullary, Multiple Endocrine Neoplasia Type 2a

Clinical Trials

Studies of Elevated Parathyroid Activity

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Cinacalcet to Treat Familial Primary Hyperparathyroidism